Theodosia Teo
0000-0003-1842-4189
Publication & Citation Trends
Publications
0 total
A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.
Cited by 4
Semantic Scholar
Abstract 5701: AU2-94: A CDK4-specific inhibitor with the marked anti-tumor efficacy
Cited by 0
Semantic Scholar
2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluation.
Cited by 16
Semantic Scholar
Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation OA
Cited by 10
Semantic Scholar
Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells OA
Cited by 6
Semantic Scholar
An Overview of CDK3 in Cancer: Clinical Significance and Pharmacological Implications.
Cited by 13
Semantic Scholar
Discovery of Potent Inhibitors of Cyclin‐Dependent Kinases 7 and 9: Design, Synthesis, Structure‐Activity Relationship Analysis and Biological Evaluation
Cited by 4
Semantic Scholar
Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation.
Cited by 6
Semantic Scholar
Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation.
Cited by 14
Semantic Scholar
CDK12: a potential therapeutic target in cancer.
Cited by 27
Semantic Scholar
Research Topics
Cancer-related Molecular Pathways
(12)
PI3K/AKT/mTOR signaling in cancer
(9)
Advanced Breast Cancer Therapies
(8)
Cancer Mechanisms and Therapy
(7)
Protein Degradation and Inhibitors
(6)
Affiliations
Commonwealth Scientific and Industrial Research Organisation
University of South Australia
Centre for Cancer Biology